Wang/NNP Laboratories/NNPS Inc./NNP ,/, Lowell/NNP ,/, Mass./NNP ,/, *-1/-NONE- beset/VBN */-NONE- by/IN declining/VBG demand/NN for/IN its/PRP$ computers/NNS ,/, reported/VBD a/DT $/$ 62.1/CD million/CD *U*/-NONE- ,/, 38-cents-a-share/JJ loss/NN in/IN its/PRP$ first/JJ quarter/NN ended/VBN Sept./NNP 30/CD ./.
Revenue/NN fell/VBD 12.7/CD %/NN to/TO $/$ 596.8/CD million/CD *U*/-NONE- from/IN $/$ 684/CD million/CD *U*/-NONE- ,/, although/IN some/DT of/IN the/DT decline/NN was/VBD caused/VBN *-1/-NONE- by/IN discontinued/JJ operations/NNS ./.
Wang/NNP had/VBD previously/RB forecast/VBN a/DT loss/NN ./.
The/DT company/NN reiterated/VBD that/IN it/PRP expects/VBZ another/DT loss/NN in/IN the/DT second/JJ quarter/NN and/CC for/IN the/DT full/JJ year/NN ,/, although/IN it/PRP expects/VBZ a/DT profitable/JJ fourth/JJ quarter/NN ./.
A/DT year/NN ago/RB ,/, Wang/NNP had/VBD earnings/NNS of/IN $/$ 13.1/CD million/CD *U*/-NONE- ,/, or/CC eight/CD cents/NNS a/DT share/NN ,/, in/IN its/PRP$ first/JJ quarter/NN ,/, including/VBG a/DT $/$ 3.1/CD million/CD *U*/-NONE- loss/NN from/IN discontinued/JJ operations/NNS ./.
The/DT latest/JJS period/NN loss/NN included/VBD a/DT $/$ 12.9/CD *U*/-NONE- pretax/JJ charge/NN for/IN severance/NN payments/NNS ./.

